Synopsis: The penny stock surged over 5% after reporting strong Q3FY26 results, with revenue up 41% YoY and net profit jumping 30,700%, reflecting sharp operational improvement. A penny-cap company, primarily engaged in the business of providing stockbroking and...
Synopsis: Premier Explosives Limited reports a 50.93% YoY drop in revenue and a 65.79% QoQ decline in net profit in Q3 FY26 results. This Defence stock, engaged in manufacturing high-energy materials, solid propellants, detonators, and explosives for defence, space,...
Synopsis: Muthoot Finance shares plunged 12% despite reporting a 103% YoY jump in Q3 FY26 PAT, as investors reacted to rising bad debts written off, stress in its microfinance subsidiary, declining capital adequacy, and heavy dependence on elevated gold prices,...
Synopsis: Ampvolts Ltd hit a 10% upper circuit after its Q3 results, and Revenue surged 1,620% YoY from ₹0.40 crore to ₹6.88 crore, while net profit turned around from a ₹0.12 crore loss to a ₹1.53 crore profit. The shares of the Penny stock company specializing in...
Synopsis: Jewellery stock gained attention after strong Q3FY26 performance, with earnings surging sharply year-on-year. The company expanded to 196 showrooms across 18 states, adding 21 stores in nine months. Despite gold prices jumping 63%, ATV rose to ₹93,000,...
Synopsis: Max Financial gains after robust Q3 performance; Jefferies reiterates Buy with 23 percent upside, backed by strong premium growth, improved margins, and solid distribution momentum. The share of this company, which is primarily engaged in growing and...
Synopsis: Angel One and Groww delivered contrasting performances in Q3 FY26. Angel One led in revenue scale with Rs 1,335 crore in income, while Groww outperformed on profitability and asset aggregation, reporting higher EBITDA margins and Rs 3 trillion in customer...
Synopsis: Bharat Forge shares rose over 4% after Q3FY26 results, with strong YoY revenue (+25%) and profit growth, a robust defence order book of Rs. 11,130 cr, and optimism for FY27, including ATAGS execution and double-digit growth. The shares of the company that...
Synopsis: A Madhusudan Kela-backed small-cap stock fell nearly 5% after reporting a ₹9.85 crore net loss, with revenue down 22% YoY and negative EBITDA. Rising inventory and margin pressures drove the decline. A small-cap company, primarily engaged in the business of...
Synopsis: Pharma stock surged 20 percent to Rs 1,377 after Q3 FY26 results, with 46 percent YoY revenue growth and 87 percent net profit rise, driven by injectables. The shares of this company, which is a manufacturer of several different types of pharma products,...
